LMT
34
2
F
58
11
PGR
65
2
BSX
67
-3
BBY
46
10
MLM
57
6
CSX
60
3
NEE
50
-5
DFS
64
2
FSLR
54
7
BMY
60
2
PEP
48
6
KMI
67
-2
A
43
2
IPG
56
3
AA
48
-12
IBM
58
-2
FE
50
-2
FITB
63
3
MSFT
50
3
LMT
34
2
F
58
11
PGR
65
2
BSX
67
-3
BBY
46
10
MLM
57
6
CSX
60
3
NEE
50
-5
DFS
64
2
FSLR
54
7
BMY
60
2
PEP
48
6
KMI
67
-2
A
43
2
IPG
56
3
AA
48
-12
IBM
58
-2
FE
50
-2
FITB
63
3
MSFT
50
3
Financhill
Back

Blueprint Medicines Stock Predictions

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37

BPMC
Blueprint Medicines

Last Price:
94.25
Seasonality Move:
5.92%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

Blueprint Medicines Stock Forecast

  • Over the next 52 weeks, Blueprint Medicines has on average historically risen by 28.8% based on the past 9 years of stock performance.
  • Blueprint Medicines has risen higher in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%
  • Is Blueprint Medicines Stock Undervalued?
    The current Blueprint Medicines [BPMC] share price is $94.15. The Score for BPMC is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Blueprint Medicines Stock Go Up Next Year?

  • Over the next 52 weeks, Blueprint Medicines has on average historically risen by 28.8% based on the past 9 years of stock performance.

Blueprint Medicines Stock Rating

Sell
37
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines overpriced?

  • Blueprint Medicines has risen higher in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%

Blueprint Medicines Stock Price History

Is BPMC stock going to rise?

  • The current trend is moderately bullish and BPMC is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
blueprintmedicines.com

52-Week Data

52-Week High:
121.90
52-Week Low:
66.61

Prediction Charts

Market Cap:
5.98B
Price in USD:
94.15
Volume:
663.53K
Beta:
0.88

Technical Analysis

SMA50:
90.42
SMA100:
95.84
SMA200:
96.05
52-Wk Change:
40.5%

Stock Predictions

  • Is Blueprint Medicines stock public?
    Yes, Blueprint Medicines is a publicly traded company.
  • What is the Blueprint Medicines stock quote today?
    The Blueprint Medicines stock price is 94.15 USD today.
  • How to buy Blueprint Medicines stock online?
    You can buy Blueprint Medicines shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 91.00 97.55 97.67 91.00
Nov-6 100.00 99.67 101.48 98.41
Nov-7 99.33 101.38 102.47 98.59
Nov-8 101.58 100.83 101.97 98.95
Nov-11 102.07 99.87 103.55 99.41
Nov-12 98.60 96.63 100.85 96.52
Nov-13 98.00 96.88 100.23 96.83
Nov-14 99.18 95.65 100.01 95.46
Nov-15 96.34 88.69 96.34 88.41
Nov-18 88.43 90.18 90.66 88.05
Nov-19 89.69 94.60 95.48 88.97
Nov-20 94.16 94.81 95.02 92.66
Nov-21 94.98 96.62 98.13 92.97
Nov-22 96.78 94.15 98.34 94.11

Blueprint Medicines Earnings

Blueprint Medicines Earnings Report: Per Share Blueprint Medicines Earnings Q1 Q2 Q3 and Q4 last year and next year.

Blueprint Medicines Forecast Revenue Growth

Blueprint Medicines Stock Analysis: Historical quarterly revenues per share for Blueprint Medicines and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.67 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.18 per share, and an increase next year of $0.64 per share.

* Blueprint Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.